References
- Aydin K, Okutur SK, Bozkurt M, et al. Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: a pilot study. Oncol Lett 2014;7:255–9
- Voldborg BR, Damstrup L, Spang-Thomsen M, et al. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997;8:1197–206
- Mahipal A, Kothari N, Gupta S. Epidermal growth factor receptor inhibitors: coming of age. Cancer Control 2014;21:74–9
- Krishnamurthy A, Vijayalakshmi R, Gadigi V, et al. The relevance of “Nonsmoking-associated lung cancer” in India: a single-centre experience. Indian J Cancer 2012;49:82–8
- Ada AO, Kunak SC, Hancer F, et al. Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population. Mol Biol Rep 2012;39:5985–93
- Yin J, Li Y, Yin M, et al. TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publications. PLoS One 2012;7:e50650
- Chen YB, Mu CY, Chen C, et al. Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population. Asia Pac J Clin Oncol 2012. [Epub ahead of print]
- Wang X, Cui E, Zeng H, et al. RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC. PLoS One 2012;7:e43734
- Choi JE, Park SH, Kim KM, et al. Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. BMC Cancer 2007;7:199
- Jou YS, Lo YL, Hsiao CF, et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients. Lung Cancer 2009;64:251–6
- Yoshida K, Nakachi K, Imai K, et al. Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose. Carcinogenesis 2009;30:2037–41
- Guo H, Xing Y, Liu R, et al. −216G/T (rs712829), a functional variant of the promoter, is associated with the pleural metastasis of lung adenocarcinoma. Oncol Lett 2013;6:693–8
- Dong J, Dai J, Shu Y, et al. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population. Carcinogenesis 2010;31:1080–6